Antibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 19291-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#19291-1-AP, RRID:AB_10643993
- Product name
- EGFL7 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated EGFL7 antibody (Cat. #19291-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Tetramethylpyrazine promotes angiogenesis and nerve regeneration and nerve defect repair in rats with spinal cord injury.
Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4.
Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin.
The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.
Role of ANKHD1/LINC00346/ZNF655 Feedback Loop in Regulating the Glioma Angiogenesis via Staufen1-Mediated mRNA Decay.
A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma.
Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
Attenuation of EGFL7 Expression Inhibits Growth Hormone-Producing Pituitary Adenomas Growth and Invasion.
EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.
Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats.
Astragalus polysaccharides exert protective effects in newborn rats with bronchopulmonary dysplasia by upregulating the expression of EGFL7 in lung tissue.
Hao Z, Yin C, Wang X, Huo Z, Zhang G, Jiang D, An M
Heliyon 2023 Nov;9(11):e21549
Heliyon 2023 Nov;9(11):e21549
Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4.
Gao Y, Wang J, Zhao M, Xia T, Liu Q, Chen N, Liao W, Zeng Z, You F, Zeng J
Frontiers in pharmacology 2022;13:797805
Frontiers in pharmacology 2022;13:797805
Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin.
Liu Q, He H, Yuan Y, Zeng H, Wang Z, Luo W
Frontiers in oncology 2020;10:74
Frontiers in oncology 2020;10:74
The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.
Salama Y, Heida AH, Yokoyama K, Takahashi S, Hattori K, Heissig B
Blood advances 2020 Mar 24;4(6):1021-1037
Blood advances 2020 Mar 24;4(6):1021-1037
Role of ANKHD1/LINC00346/ZNF655 Feedback Loop in Regulating the Glioma Angiogenesis via Staufen1-Mediated mRNA Decay.
Yang C, Zheng J, Liu X, Xue Y, He Q, Dong Y, Wang D, Li Z, Liu L, Ma J, Cai H, Liu Y
Molecular therapy. Nucleic acids 2020 Jun 5;20:866-878
Molecular therapy. Nucleic acids 2020 Jun 5;20:866-878
A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Zhai W, Zhu R, Ma J, Gong D, Zhang H, Zhang J, Chen Y, Huang Y, Zheng J, Xue W
Molecular cancer 2019 Apr 5;18(1):81
Molecular cancer 2019 Apr 5;18(1):81
Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma.
Mammola CL, Vetuschi A, Pannarale L, Sferra R, Mancinelli R
European journal of histochemistry : EJH 2018 Nov 30;62(4)
European journal of histochemistry : EJH 2018 Nov 30;62(4)
Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
Liu Q, Zhang J, Gao H, Yuan T, Kang J, Jin L, Gui S, Zhang Y
Science China. Life sciences 2018 Aug;61(8):893-901
Science China. Life sciences 2018 Aug;61(8):893-901
Attenuation of EGFL7 Expression Inhibits Growth Hormone-Producing Pituitary Adenomas Growth and Invasion.
Liu Q, Wang J, Yang H, Gao H, Li C, Lan X, Zhang Y
Human gene therapy 2018 Apr 2;
Human gene therapy 2018 Apr 2;
EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.
Wang J, Liu Q, Gao H, Wan D, Li C, Li Z, Zhang Y
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Jul;39(7):1010428317706203
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Jul;39(7):1010428317706203
Erythropoietin attenuates hyperoxia-induced lung injury by upregulating epidermal growth factor-like domain 7 in newborn rats.
Cui H, He J, Chen H, Chen J, Qian X, Huang W
Biomedical reports 2017 Jan;6(1):32-38
Biomedical reports 2017 Jan;6(1):32-38
Astragalus polysaccharides exert protective effects in newborn rats with bronchopulmonary dysplasia by upregulating the expression of EGFL7 in lung tissue.
Wang XH, Huang WM
International journal of molecular medicine 2014 Dec;34(6):1529-36
International journal of molecular medicine 2014 Dec;34(6):1529-36
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human heart tissue were subjected to SDS PAGE followed by western blot with 19291-1-AP(EGFL7 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The EGFL7 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human EGFL7. This antibody recognizes human,mouse,rat antigen. The EGFL7 antibody has been validated for the following applications: ELISA, WB, IHC analysis.